Top Suppliers:I want be here

199191-69-0

199191-69-0 structure
199191-69-0 structure
  • Name: Ziprasidone mesilate
  • Chemical Name: ziprasidone mesylate trihydrate
  • CAS Number: 199191-69-0
  • Molecular Formula: C22H31ClN4O7S2
  • Molecular Weight: 563.087
  • Catalog: analytical chemistry Standard Pharmacopoeia Standards and Magazine Standards
  • Create Date: 2018-08-13 19:02:11
  • Modify Date: 2024-01-02 16:04:36
  • Ziprasidone (CP-88059) mesylate trihydrate is an orally active combined 5-HT and dopamine receptor antagonist[1]. Ziprasidone mesylate trihydrate has affinities for Rat D2 (Ki=4.8 nM), 5-HT2A (Ki=0.42 nM) and 5-HT1A (Ki=3.4 nM)[1].

Name ziprasidone mesylate trihydrate
Synonyms 5-(2-(4-(1,2-benzisothiazol-3-yl)-1-piperazinyl)ethyl)-6-chloro-1,3-dihydro-2h-indol-2-one
anhydrous 5-(2-(4-(1,2-benzisothiazol-3-yl)-1-piperazinyl)ethyl)-6-chloro-1,3-dihydro-2H-indol-2-one
Ziprasidone
Ziprasidone mesilate
2H-INDOL-2-ONE,5-[2-[4-(1,2-BENZISOTHIAZOL-3-YL)-1-PIPERAZINYL]ETHYL]-6-CHLORO-1,3-DIHYDRO-,MONOMETHANESULFONATE,TRIHYDRATE
[14C]-Ziprasidone
5-[2-[4-(1,2-benzisothiazol-3yl)-1-piperazinyl]ethyl]-6-chloro-1,3-dihydro-2h-indol-2-one mesilate
[3H]-Ziprasidone
Ziprasidone mesylate trihydrate
5-{2-[4-(1,2-Benzothiazol-3-yl)-1-piperazinyl]ethyl}-6-chloro-1,3-dihydro-2H-indol-2-one methanesulfonate hydrate (1:1:3)
2H-Indol-2-one, 5-[2-[4-(1,2-benzisothiazol-3-yl)-1-piperazinyl]ethyl]-6-chloro-1,3-dihydro-, methanesulfonate, hydrate (1:1:3)
ZIPRASIDONE MESYLATE
Description Ziprasidone (CP-88059) mesylate trihydrate is an orally active combined 5-HT and dopamine receptor antagonist[1]. Ziprasidone mesylate trihydrate has affinities for Rat D2 (Ki=4.8 nM), 5-HT2A (Ki=0.42 nM) and 5-HT1A (Ki=3.4 nM)[1].
Related Catalog
Target

Rat 5-HT2 Receptor:0.42 nM (Ki)

Rat 5-HT1A Receptor:3.4 nM (Ki)

Rat D2 Receptor:4.8 nM (Ki)

In Vitro Ziprasidone mesylate trihydrate (0-500 nM, 150 seconds) blocks wild-type hERG current[2]. Cell Viability Assay Cell Line: HEK-293 cells[2] Concentration: 0-500 nM Incubation Time: 150 seconds Result: Blocked wild-type hERG current in a voltage- and concentration-dependent manner (IC50 = 120 nm).
In Vivo Ziprasidone mesylate trihydrate (oral gavage; 20 mg/kg; once daily; 7 weeks) results in weight loss, low level physical activity, high resting energy expenditure and greater capacity for thermogenesis when subjected to cold[3]. Animal Model: Eight-week-old female Sprague-Dawley rats weighing 200 to 250 g[3] Dosage: 20 mg/kg Administration: Oral gavage; 20 mg/kg; once daily; 7 weeks Result: Gained significantly less weight (P = 0.031), had a lower level of physical activity (P = 0.016), showed a higher resting energy expenditure (P < 0.001), and displayed a greater capacity for thermogenesis when subjected to cold (P < 0.001).
References

[1]. H Rollema, et al. 5-HT(1A) receptor activation contributes to ziprasidone-induced dopamine release in the rat prefrontal cortex. Biol Psychiatry. 2000 Aug 1;48(3):229-37.

[2]. Zhi Su, et al. Block of hERG channel by ziprasidone: biophysical properties and molecular determinants. Biochem Pharmacol. 2006 Jan 12;71(3):278-86.

[3]. Subin Park, et al. The effect of ziprasidone on body weight and energy expenditure in female rats. Metabolism. 2012 Jun;61(6):787-93.

Boiling Point 554.8ºC at 760 mmHg
Molecular Formula C22H31ClN4O7S2
Molecular Weight 563.087
Exact Mass 562.132263
PSA 167.15000
LogP 4.34180
Vapour Pressure 1.13E-29mmHg at 25°C